Showing results (71-80 of 96) with videos related to

Sort By:
Pageof 10
Cancer Research|October 11, 2017
MALT1 Inhibition Is Efficacious in Both Naïve and Ibrutinib-Resistant Chronic Lymphocytic LeukemiaNakhle S Saba, Deanna H Wong, Georges Tanios, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 19, 2015
Interactions between Ibrutinib and Anti-CD20 Antibodies: Competing Effects on the Outcome of Combination TherapyMartin Skarzynski, Carsten U Niemann, Yuh Shan Lee, et al.
Leukemia|July 20, 2016
Ibrutinib downregulates a subset of miRNA leading to upregulation of tumor suppressors and inhibition of cell proliferation in chronic lymphocytic leukemiaL M Saleh, W Wang, S E M Herman, et al.
Blood|August 14, 2013
Egress of CD19(+)CD5(+) cells into peripheral blood following treatment with the Bruton tyrosine kinase inhibitor ibrutinib in mantle cell lymphoma patientsBetty Y Chang, Michelle Francesco, Martin F M De Rooij, et al.
Blood|June 5, 2010
Phosphatidylinositol 3-kinase-δ inhibitor CAL-101 shows promising preclinical activity in chronic lymphocytic leukemia by antagonizing intrinsic and extrinsic cellular survival signalsSarah E M Herman, Amber L Gordon, Amy J Wagner, et al.
Blood|October 21, 2010
CAL-101, a p110delta selective phosphatidylinositol-3-kinase inhibitor for the treatment of B-cell malignancies, inhibits PI3K signaling and cellular viabilityBrian J Lannutti, Sarah A Meadows, Sarah E M Herman, et al.
Haematologica|October 3, 2015
Incidence and risk factors of bleeding-related adverse events in patients with chronic lymphocytic leukemia treated with ibrutinibAndrew H Lipsky, Mohammed Z H Farooqui, Xin Tian, et al.
Blood|April 30, 2016
Pathogenic role of B-cell receptor signaling and canonical NF-κB activation in mantle cell lymphomaNakhle S Saba, Delong Liu, Sarah E M Herman, et al.
Blood|September 5, 2015
Partial reconstitution of humoral immunity and fewer infections in patients with chronic lymphocytic leukemia treated with ibrutinibClare Sun, Xin Tian, Yuh Shan Lee, et al.
Blood|January 5, 2017
Clonal evolution leading to ibrutinib resistance in chronic lymphocytic leukemiaInhye E Ahn, Chingiz Underbayev, Adam Albitar, et al.
Pageof 10